<?xml version="1.0" encoding="UTF-8"?><iati-activities generated-datetime="2026-11-04T21:06:34.7322734+00:00" version="2.03"><iati-activity last-updated-datetime="2026-10-31T00:00:00+00:00" xml:lang="en" default-currency="USD" hierarchy="1"><iati-identifier>GB-CHC-1099776-I5</iati-identifier><reporting-org xml:lang="en" ref="GB-CHC-1099776" type="21"><narrative>Malaria Consortium</narrative></reporting-org><title xml:lang="en"><narrative>IPTi DAC Training Planning BMGF</narrative></title><description xml:lang="en" type="1"><narrative>Intermittent Preventive Treatment During Infancy DAC Trial Planning Grant. "Charitable Purpose": to enhance the informativeness and impact of the Nigeria Operational Feasibility and Effectiveness IPTi study by applying rigorous research methods for study design, analysis and communication to the proposed study plan.</narrative></description><participating-org xml:lang="en" ref="DAC-1601" type="60" role="1"><narrative>Bill &amp; Melinda Gates Foundation</narrative></participating-org><activity-status code="2" /><activity-date type="2" iso-date="2021-10-08" /><activity-date type="3" iso-date="2022-12-31" /><contact-info type="1"><organisation><narrative>Malaria Consortium</narrative></organisation><person-name><narrative>Malaria Consortium</narrative></person-name><email>iati@malariaconsortium.org</email><mailing-address><narrative>The Green House, 244-254 Cambridge Heath Road, London, E2 9DA, United Kingdom</narrative></mailing-address></contact-info><recipient-country code="NG" percentage="100.000000000000000000" /><sector vocabulary="1" code="12262" percentage="100.000000000000000000"><narrative>Malaria control</narrative></sector><default-flow-type code="10" /><default-finance-type code="110" /><default-tied-status code="5" /><budget type="1"><period-start iso-date="2021-10-08" /><period-end iso-date="2022-12-31" /><value value-date="2021-10-08" currency="USD">215497</value></budget><transaction><transaction-type code="1" /><transaction-date iso-date="2022-04-01" /><value currency="USD" value-date="2022-04-01">215497</value><provider-org><narrative>Bill &amp; Melinda Gates Foundation</narrative></provider-org><disbursement-channel code="2" /><flow-type code="10" /><finance-type code="110" /><tied-status code="5" /></transaction><transaction><transaction-type code="2" /><transaction-date iso-date="2021-10-08" /><value currency="USD" value-date="2021-10-08">215497</value><provider-org ref="DAC-1601"><narrative>Bill &amp; Melinda Gates Foundation</narrative></provider-org><disbursement-channel code="2" /><flow-type code="10" /><finance-type code="110" /><tied-status code="5" /></transaction><related-activity ref="GB-CHC-1099776-I5-NG" type="2" /></iati-activity><iati-activity last-updated-datetime="2026-10-31T00:00:00+00:00" xml:lang="en" default-currency="USD" hierarchy="2"><iati-identifier>GB-CHC-1099776-I5-NG</iati-identifier><reporting-org xml:lang="en" ref="GB-CHC-1099776" type="21"><narrative>Malaria Consortium</narrative></reporting-org><title xml:lang="en"><narrative>IPTi DAC Training Planning BMGF [Nigeria]</narrative></title><description xml:lang="en" type="1"><narrative>Intermittent Preventive Treatment During Infancy DAC Trial Planning Grant. "Charitable Purpose": to enhance the informativeness and impact of the Nigeria Operational Feasibility and Effectiveness IPTi study by applying rigorous research methods for study design, analysis and communication to the proposed study plan. [Nigeria]</narrative></description><participating-org xml:lang="en" ref="GB-CHC-1099776" type="21" role="4"><narrative>Malaria Consortium</narrative></participating-org><activity-status code="2" /><activity-date type="2" iso-date="2021-10-08" /><activity-date type="3" iso-date="2022-12-31" /><contact-info type="1"><organisation><narrative>Malaria Consortium</narrative></organisation><person-name><narrative>Malaria Consortium</narrative></person-name><email>iati@malariaconsortium.org</email><mailing-address><narrative>The Green House, 244-254 Cambridge Heath Road, London, E2 9DA, United Kingdom</narrative></mailing-address></contact-info><recipient-country code="NG" percentage="100.000000000000000000" /><sector vocabulary="1" code="12262" percentage="100.000000000000000000"><narrative>Malaria control</narrative></sector><default-flow-type code="10" /><default-finance-type code="110" /><default-tied-status code="5" /><transaction><transaction-type code="4" /><transaction-date iso-date="2022-03-31" /><value currency="USD" value-date="2022-03-31">7246</value><disbursement-channel code="2" /><flow-type code="10" /><finance-type code="110" /><tied-status code="5" /></transaction><transaction><transaction-type code="4" /><transaction-date iso-date="2022-06-30" /><value currency="USD" value-date="2022-06-30">449</value><disbursement-channel code="2" /><flow-type code="10" /><finance-type code="110" /><tied-status code="5" /></transaction><transaction><transaction-type code="4" /><transaction-date iso-date="2022-09-30" /><value currency="USD" value-date="2022-09-30">35105</value><disbursement-channel code="2" /><flow-type code="10" /><finance-type code="110" /><tied-status code="5" /></transaction><related-activity ref="GB-CHC-1099776-I5" type="1" /></iati-activity></iati-activities>
